Altamont Pharma Acquisition Corp.
Withdrawn
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $100M
- Underwriters
- Focus
- Biopharmaceuticals, Healthcare, Technology
- SEC Filings
- 1845136
- Public Embarc Page
- https://embarc.com/capital/spac/1845136/ALTP/altamont-pharma-acquisition
SPAC Leadership
Information on the SPAC leadership.
- President and Chief Executive Officer and ChairmanMark Pearson
- Senior Director of FinanceRhozel Ocampo
- Senior Investment Officer and AnalystYitai Tang, Ph.D.
- Senior AnalystGayathri Srinivasan
- DirectorSharon Tetlow
- DirectorJohn D. Harkey, Jr.
- DirectorJay Shepard
- DirectorLisa Walters-Hoffert